Abstract
The use of quality of life (QOL) measurement in the End-Stage Renal Disease (ESRD) setting can be useful to measure the impact of interventions on outcomes. Using QOL results can also increase patient participation in care planning and, thus, increase patient satisfaction with care. Clinical indicators can be developed to trigger further assessment of various patient needs.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
